Molecule Structure

Scientific Name


Description of the Drug

Relugolix is an oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)


Company Owner(s)

Myovant Sciences Gmbh

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Gonadotropin-releasing hormone receptor SINGLE PROTEIN ANTAGONIST CHEMBL1855

Unichem Links

Human Metabolome Database HMDB0304861
DrugBank DB11853
PubChem: Thomson Pharma 15360452
PubChem 10348973
BindingDB 50347982
EPA CompTox Dashboard DTXSID40224167
DrugCentral 5432
ChemicalBook CB42658205
Guide to Pharmacology 5586
ZINC ZINC000043206033